Immunologic reactivity of lymphoid cells in tumors.
作者信息
Herberman R B, Holden H T, Varesio L, Taniyama T, Puccetti P, Kirchner H, Gerson J, White S, Keisari Y, Haskill J S
出版信息
Contemp Top Immunobiol. 1980;10:61-78. doi: 10.1007/978-1-4684-3677-8_3.
PMID:6967800
Abstract
摘要
相似文献
1
Immunologic reactivity of lymphoid cells in tumors.肿瘤中淋巴细胞的免疫反应性。
Contemp Top Immunobiol. 1980;10:61-78. doi: 10.1007/978-1-4684-3677-8_3.
2
Intratumor host cells of experimental rat neoplasms: characterization and effector function.实验大鼠肿瘤中的肿瘤内宿主细胞：特征与效应功能
Contemp Top Immunobiol. 1980;10:109-42. doi: 10.1007/978-1-4684-3677-8_5.
3
4
The influence of histamine on immune and inflammatory responses.组胺对免疫和炎症反应的影响。
Adv Immunol. 1984;35:209-68. doi: 10.1016/s0065-2776(08)60577-5.
5
Frequency determination of killer cells by a single-cell cytotoxic assay.通过单细胞细胞毒性试验测定杀伤细胞的频率
Methods Enzymol. 1983;93:270-80. doi: 10.1016/s0076-6879(83)93049-5.
6
Anti-tumour cytotoxic effects mediated by minor and major cell populations of lymph nodes.淋巴结中主要和次要细胞群体介导的抗肿瘤细胞毒性作用。
Nature. 1974 Nov 29;252(5482):420-1. doi: 10.1038/252420a0.
7
8
[Cells involved in immune responeses and their roles (author's transl)].参与免疫反应的细胞及其作用（作者译）
Nihon Hifuka Gakkai Zasshi. 1978 Sep;88(10):607-13.
9
Natural killer and other effector cells.自然杀伤细胞及其他效应细胞。
Symp Fundam Cancer Res. 1986;38:221-58.
10
The interplay of lymphoid cells and macrophages in tumour immunity.肿瘤免疫中淋巴细胞与巨噬细胞的相互作用。
Ann Inst Pasteur (Paris). 1972 Apr;122(4):645-58.
引用本文的文献
1
In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line.HT-29人结肠腺癌细胞系对肿瘤的体内延迟排斥反应及对迟发型超敏反应的抑制作用。
Cancer Immunol Immunother. 1987;24(3):225-30. doi: 10.1007/BF00205634.
2
The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens.在对肿瘤抗原产生耐受的小鼠的肿瘤块中产生肿瘤特异性体内保护性免疫。
Cancer Immunol Immunother. 1987;25(2):105-10. doi: 10.1007/BF00199949.
3
Mechanisms for recognition of tumor antigens and mediation of anti-tumor effect by noncytolytic Lyt-2+ T cell subset.非细胞溶解性Lyt-2+ T细胞亚群识别肿瘤抗原及介导抗肿瘤效应的机制。
Jpn J Cancer Res. 1988 Jan;79(1):99-108. doi: 10.1111/j.1349-7006.1988.tb00016.x.
4
Mediation of in vivo tumor-neutralizing activity by Lyt-2+ as well as L3T4+ T cell subsets.Lyt-2+以及L3T4+ T细胞亚群对体内肿瘤中和活性的介导作用。
Jpn J Cancer Res. 1988 Jan;79(1):91-8. doi: 10.1111/j.1349-7006.1988.tb00015.x.
5
Functional capacity of a tumor-infiltrating B-cell line: lymphokine secretion.肿瘤浸润性B细胞系的功能能力：淋巴因子分泌
Immunol Res. 1992;11(1):34-41. doi: 10.1007/BF02918606.
6
Tumor-specific T cell lines: capacity to proliferate and produce interleukin 2 in response to various forms of tumor antigens.肿瘤特异性T细胞系：对各种形式的肿瘤抗原作出反应时增殖并产生白细胞介素2的能力。
Jpn J Cancer Res. 1992 Feb;83(2):184-93. doi: 10.1111/j.1349-7006.1992.tb00085.x.
Zotero 插件